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ABSTRACT 
Most sterols, such as cholesterol and ergosterol, become functional only after the 
removal of the two methyl groups at C-4 from their biosynthetic precursors. 
Nevertheless, some findings suggest that 4,4-dimethyl sterols might be involved in 
specific physiological processes. In this paper we present the synthesis of a collection 
of analogues of 4,4-dimethyl sterols with a diamide side chain and a preliminary 
analysis of their in vitro activity on selected biological systems. The key step for the 
synthesis involves an Ugi condensation, a versatile multicomponent reaction. Some of 
the new compounds showed antifungal and cytotoxic activity. 
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INTRODUCTION 
Sterols have an extremely widespread distribution in living organisms: protozoa, algae, 
fungi, higher plants and animals [1]. Although sterols have multiple roles, the most 
important is as structural constituents of eukaryote membranes, where they enhance 
the packing of the acyl chains of phospholipids in the hydrophobic phase of the bilayer, 
increase its mechanical strength, and reduce its permeability [2].  
The outline for similarity and differences in sterol biosynthesis across kingdoms has 
been established [3]. Although the most abundant sterols are cholesterol, ergosterol 
and sitosterol [1], chemical surveys of the sterol composition of eukaryotes show that 
there are at least 250 different sterols, many of them being biosynthetic intermediates, 
present in small amounts in tissues. Taking into account that all sterols derive from the 
lanostane or cycloartane skeletons, many of these intermediates possess methyl 
groups at C-4 and/or C-14.  
Most sterols become functional only after the removal of the two methyl groups at C-4 
[4]. Nevertheless, some reports indicate that a variety of C-4 methylated sterols have 
specific physiological activity in different organisms. In animals, for example, 4,4-
dimethyl-5α-cholesta-8,14,24-trien-3β-ol and related sterols can activate the nuclear 
maturation of oocytes and markedly improve fertilization rates in vitro [5]. On the other 
hand, recent studies show that 4-methylsterols regulate Schizosaccharomyces pombe 
fission under low oxygen and cell stress [6]. 
  
Synthetic, non natural 4,4-dimethylsterols may have biological activities also: both 4,4-
dimethylcholestrol (1) and 4,4-dimethylcholest-5-en-3-one (2) (Figure 1) are able to 
suppress the inflammatory response induced by a phorbol derivative on mice skin [7].  
In recent papers we have shown that some sterol analogues with a diamide side chain 
are able to exert some interesting biological activities. Particularly, compounds 3 and 4 
(Figure 2) showed inhibitory effect on the growth of fungi associated with plant 
pathologies, but have a low in vitro toxicity in mammalian cells [8,9]. Furthermore, our 
previous findings suggest that an aromatic fragment bound to the N-22 is important for 
the activity.  
Taking these previous results into account, in this paper we describe the synthesis of a 
small library of 4,4-dimethyl sterol analogues with a general structure 5, structurally 
related to 3 and 4, and some preliminary in vitro studies about their effect on eukaryotic 
cells.  
 
EXPERIMENTAL 
SYNTHESIS 
General 
All the reagents were purchased from Sigma-Aldrich Chemical Co. ESI-HRMS were 
measured on a Bruker micrOTOF-Q II. Melting points were determined on a Fisher 
Johns apparatus and are uncorrected. All NMR spectra were recorded on a Bruker AM-
500 (500 MHz for 1H and 125.1 MHz for 13C). Chemical shifts (δ) are given in ppm 
downfield from TMS as the internal standard. Coupling constant (J) values are in Hz. 
All solvents and reagents were of analytical grade. All new compounds gave 
satisfactory combustion analysis data (purity ≥ 98%) on an Exeter CE 440 Elemental 
Analyzer.  
 
Methyl (17β)-4,4-dimethyl-3-oxoandrost-5-ene-17-carboxylate (7) 
Methyl (17β)-3-oxoandrost-4-ene-17-carboxylate [10]  (6, 1.6 g, 4.8 mmol, obtained 
from progesterone as previously described [11]) was dissolved in anhydrous THF (100 
ml) under argon, and potassium t-butoxide (1.1 g, 9.6 mmol) was added in portions. 
After stirring the yellow solution for 5 min at 0 ºC, methyl iodide (13,7 g, 6.03 ml, 96 
mmol) was added, after which the solution becomes cloudy yellow. The reaction was 
monitored by TLC, and completed within 60 minutes. Then, H2O (20 ml) and saturated 
solution of ammonium chloride (20 ml) were added. The mixture was evaporated in 
vacuo in order to get rid of the THF. The residue was taken in ethyl acetate (200 ml), 
washed with brine, dried over Na2SO4 and evaporated in vacuo to give 1.72 g of a 
yellow oil crude product, which was subsequently purified by column chromatography 
  
on silica (cyclohexane / EtOAc 95:5) to give the dimethylated product 7 (771 mg, 2.1 
mmol, 63%). M.p.:123-125°C. 1H NMR (CDCl3): 0.67 (H18, 3H, s); 0.85 (H19, 3H, s); 
1.23 (H4a and H4b, 6H, s); 1.51 (H8, 1H, dq, J = 10.7 and 5.5); 2.36 (H17, 1H, t, J = 
9.4); 2.47 (H2β, 1H, ddd, J = 18.9, 8.4 and 1.7); 2.56 (H2α, 1H, ddd, J = 18.9, 11.1 and 
8.2); 3.03 (-CO-CH3, 3H, s); 5.55 (H6, 1H, dd, J = 5.3 and 2.5). 13C NMR (CDCl3): 13.6 
(C18); 19.6 (C19); 21.4 (C11); 23.9 (C16); 24.7 (C15); 27.5 (C4b); 30.4 (C4a); 31.6 
(C8); 31.9 (C7); 32.4 (C1); 33.9 (C2); 37.4 (C10); 38.4 (C12); 44.2 (C13); 48.9 (C4); 
49.1 (C9); 51.5 (-CO-CH3); 55.4 (C17); 56.4 (C14); 119.9 (C6); 150.1 (C5); 174.7 
(C20); 216.8 (C3). Anal. calculated for C23H34O3 C, 77.05; H, 9.56; found: C, 77.11; H, 
9.67. 
 
(17β)-4,4-Dimethyl-3-oxoandrost-5-ene-17-carboxylic acid. (8) 
To a solution of ester 7 (771 mg, 2.1 mmol) in ethylene glycol (10.5 ml) an aqueous 
solution of KOH (1.82 ml, 40 % m/v) was added, and the resulting suspension was 
heated under reflux for 20 minutes until a clear solution was formed. Then H2O (50 ml) 
and HCl 10% (50 ml) were added, and the precipitate extracted with EtOAc (3x20 ml). 
The organic fraction was dried over Na2SO4 and evaporated in vacuo. The crude 
product was purified by column chromatography on silica (hexane / EtOAc gradient), to 
yield the steroidal acid 8 (511 mg,67% yield). M.p.: 217-218°C. 1H NMR (CDCl3): 0.73 
(H18, 3H, s); 0.85 (H19, 3H, s); 1.21 (H4a, 3H, s); 1.23 (H4b, 3H, s); 1.51 (H8, 1H, dq, 
J = 10.6 and 5.4); 2.33 (H17, 1H, t, J = 9.3); 2.45 (H2β, 1H, m); 2.56 (H2α, 1H, m); 5.56 
(H6, 1H, dd, J = 5.2 and 2.5). 13C NMR (CDCl3): 12.6 (C18); 18.6 (C19); 20.4 (C11); 
22.9 (C16); 23.7 (C15); 26.6 (C4a); 29.5 (C4b); 30.6 (C8); 30.9 (C7); 31.3 (C2); 33.0 
(C1); 36.2 (C10); 37.2 (C12); 42.9 (C13); 47.7 (C4); 48.1 (C9); 54.4 (C17); 55.5 (C14); 
119.0 (C6); 149.0 (C5); 175.2 (C20); 215.7 (C3). Anal. calculated for C22H32O3 C, 
76.77; H, 9.36; found: C, 76.88; H, 9.45. 
 
(17β)-N-((t-butylcarbamoyl)methyl)-N-(4-methoxyphenyl)-4,4-dimethyl-3-oxoandrost-5-
ene-17-carboxamide (9a). 
To a solution of the aniline (0.07 mmol, 1.1 eq.) in methanol (1 ml), 5 µL of 
formaldehyde (37% aq) was added, and the mixture was stirred for 30 minutes at room 
temperature. Then, 20 mg of the steroidal acid 8 (0.06 mmol, 1 eq.) and t-butyl 
isocyanide (6.6 µL, 0.07 mmol, 1.1 eq.) were added. The reaction was kept under the 
same condition until total disappearance of the acid (72 h). The solvent was 
evaporated under reduced pressure and the residue was taken in EtOAc and washed 
with NaOH (5% aq.). The crude product was purified by silica gel column 
chromatography (hexane / EtOAc gradient) to give compound 9a with a 66% yield. 
  
M.p.: 174°C. 1H NMR (CDCl3): 0.83 (H18, 3H, s); 0.84 (H19, 3H, s); 1.19 (H4b, 3H, s); 
1.21 (H4a, 3H, s); 1.36 (-NH-C(CH3)3, 9H, s); 1.52 (H8, 1H, m); 2.47 (H2β, 1H, m); 2.50 
(H17, 1H, t, J = 9.1); 2.56 (H2α, 1H, m); 3,83 (-N-Ar-OCH3, 3H, s); 3.86 (-N(Ar)-CHaHb-
CO-, 1H, d, J = 14.5); 4.38 (-N-CHaHb-CO-, 1H, d, J = 14.5); 5.50 (H6, 1H, dd, J = 2.5 
and 5.2); 6.42 (-NH-C(CH3)3, 1H, bs); 6.89 (2H, d, J = 9 ) and 7.12 (2H, m). 
13C NMR (CDCl3): 13.8 (C18); 19.3 (C19); 21.0 (C11); 24.6 (C15); 26.1 (C16); 27.2 
(C4a); 28.7 (-NH-C(CH3)3); 30.1 (C4b); 31.1 (C8); 31.6 (C7); 32.1 (C1); 33.6 (C2); 37.1 
(C10); 38.3 (C12); 38.7 (C13); 45.3 (C4); 48.6 (C9); 51.0 (-NH-C(CH3)3); 51.5 (C17); 
55.4 (-N-Ar-OCH3); 56.1 (-N-CH2-CO-); 56.2 (C14); 114.6, 129.9, 136.3 and 158.9 
(aromatic carbons); 119.6 (C6); 149.8 (C5); 168.7 (-N(Ar)CH2-CO-); 175.1 (C20); 216.5 
(C3). HRMS (ESI): calculated for [M+H+] C28H44NO4 458.3265, found 458.3289. Anal. 
calculated for C33H48N2O3 C, 76.11; H, 9.29; N, 5.38; found: C, 76.21; H, 9.41; N, 5.21. 
 
Further elution gave 12% of 2-(t-butylamino)-2-oxoethyl (17β)-4,4-dimethyl-3-
oxoandrost-5-ene-17-carboxylate (10), the Passerini condensation product. M. p.: 131-
133 ºC. 1H NMR (CDCl3): 0.73 (H18, 3H, s); 0.73 (H18, 3H, s); 0.86 (H19, 3H, s); 1.24 
(H4a and H4b, 6H, s); 1.38 (-NH-C(CH3)3, 9H, s); 1.54 (H8, 1H, m); 2.45 (H17, 1H, t, J 
= 9.3); 2.48 (H2β, 1H, ddd, J =18.9, 8.5 and 1.7); 2.57 (H2α, 1H, ddd, J =18.9, 8.5 and 
1.7); 4.42 (-CO-CHaHb-CO-, 1H, d, J = 15.1); 4.51 (-CO-CHaHb-CO-, 1H, d, J = 15.1); 
5.56 (H6, 1H, dd, J = 5.24 and 2.5); 13C NMR (CDCl3): 13.7 (C18); 19.5 (C19); 21.3 
(C11); 23.9 (C16); 24.5 (C15); 27.4 (C4a); 28.9 (C26); 30.3 (C4b); 31.5 (C8); 31.7 (C7); 
32.3 (C1); 33.8 (C2); 37.3 (C10); 38.6 (C12); 44.4 (C13); 48.8 (C4); 49.0 (C9); 51.5 (-
NH-C(CH3)3); 55.2 (C17); 56.4 (C14); 63.4 (-CO-CH2-CO-); 119.7 (C6); 150.1 (C5); 
166.4(-CO-CH2-CO-); 172.5 (C20); 216.6 (C3). HRMS (ESI): calculated for [M+H+] 
C28H44NO4 458.3265, found 458.3265. Anal. calculated for C33H48N2O3 C, 76.11; H, 
9.29; N, 5.38; found:C, 76.21; H, 9.41; N, 5.21. 
 
The same procedure was repeated with different amines to give compounds 9b-i, that 
in all cases were obtained with a small amount (between 5% to 15%) of compound 10 
 
(17β)-N-((t-butylcarbamoyl)methyl)-N-(4-chlorophenyl)-4,4-dimethyl-3-oxoandrost-5-
ene-17-carboxamide  (9b).  
M.p.: 158-160°C. HRMS (ESI+): calculated for [M+Na+] C34H47ClN2NaO3 589.3167, 
found 589.3203.  
 
(17β)-N-((t-butylcarbamoyl)methyl)-N-phenyl-4,4-dimethyl-3-oxoandrost-5-ene-17-
carboxamide  (9c) 
  
Colourless oil. HRMS (ESI+): calculated for [M+Na+] C34H48N2NaO3 555.3557, found 
555.3562.  
 
(17β)-N-((t-butylcarbamoyl)methyl)-N-(4-methylphenyl)-4,4-dimethyl-3-oxoandrost-5-
ene-17-carboxamide  (9d) 
M.p.: 184°C. HRMS (ESI+): calculated for [M+Na+] C35H50N2NaO3 569.3714, found 
569.3734.  
 
(17β)-N-((t-butylcarbamoyl)methyl)-N-(2-chlorophenyl)-4,4-dimethyl-3-oxoandrost-5-
ene-17-carboxamide  (9e) 
M.p.: 89-91°C. HRMS (ESI+): calculated for [M+Na+] C34H47ClN2NaO3 589.3167, found 
589.3180.  
 
(17β)-N-((t-butylcarbamoyl)methyl)-N-(2-fluorophenyl)-4,4-dimethyl-3-oxoandrost-5-
ene-17-carboxamide  (9f) 
Colourless oil. HRMS (ESI+): calculated for [M+Na+] C34H47FN2NaO3 573.3463, found 
573.3467.  
 
(17β)-N-((t-butylcarbamoyl)methyl)-N-(2-ethyl-6-methylphenyl)-4,4-dimethyl-3-
oxoandrost-5-ene-17-carboxamide  (9g) 
M.p.: 110ºC HRMS (ESI+): calculated for [M+Na+] C37H54N2NaO3 597.4027, found 
597.4050.  
 
(17β)-N-((t-butylcarbamoyl)methyl)-N-(2-naphthyl)-4,4-dimethyl-3-oxoandrost-5-ene-
17-carboxamide  (9h) 
Colourless oil. HRMS (ESI+): calculated for [M+Na+] C38H50N2NaO3 605.3714, found 
605.3679.  
 
(17β)-N-((t-butylcarbamoyl)methyl)-N-(4-fluorophenyl)-4,4-dimethyl-3-oxoandrost-5-
ene-17-carboxamide  (9i) 
Colourless oil. HRMS (ESI+): calculated for [M+Na+] C34H47FN2NaO3 573.3463, found 
573.3481.  
 
(17β)-N-((t-butylcarbamoyl)methyl)-N-(4-methoxyphenyl)-4,4-dimethyl-3-
hydroxyandrost-5-ene-17-carboxamide  (5a). 
Compound 9a (13 mg, 0.02 mmol) was dissolved in 2 ml of CH2Cl2 / MeOH (1:1) and 
NaBH4 (2 eq.) were added. The resulting slurry was stirred at room temperature for 15 
  
minutes, until completion of the reaction. The solvent were removed in vacuo, and the 
crude product was purified by column chromatography on silica (hexane / EtOAc 
gradient) to give compound 5a with 95% yield. M.p.: 248°C. HRMS (ESI+): calculated 
for [M+Na+] C35H52N2NaO4 587.3819, found 587.3849. 
 
The same procedure was used for the reduction of the 3-oxo moiety in compounds 9b-i 
and 10, to give the corresponding 3β-hydroxy analogs. 
 
(17β)-N-((t-butylcarbamoyl)methyl)-N-(4-chlorophenyl)-4,4-dimethyl-3-hydroxyandrost-
5-ene-17-carboxamide  (5b) 
M.p.: 122-124°C. HRMS (ESI+): calculated for [M+Na+] C34H49ClN2NaO3 591.3324, 
found 591.3304. 
 
(17β)-N-((t-butylcarbamoyl)methyl)-N-phenyl-4,4-dimethyl-3-hydroxyandrost-5-ene-17-
carboxamide  (5c) 
Colourless oil. HRMS (ESI+): calculated for [M+Na+] C34H50N2NaO3 557.3714, found 
557.3753. 
 
(17β)-N-((t-butylcarbamoyl)methyl)-N-(4-methylphenyl)-4,4-dimethyl-3-hydroxyandrost-
5-ene-17-carboxamide  (5d) 
M.p.: 202-204ºC. HRMS (ESI+): calculated for [M+Na+] C35H52N2NaO3 571.3870, found 
571.3882. 
 
(17β)-N-((t-butylcarbamoyl)methyl)-N-(2-chlorophenyl)-4,4-dimethyl-3-hydroxyandrost-
5-ene-17-carboxamide  (5e) 
Colourless oil. HRMS (ESI+): calculated for [M+Na+] C34H49ClN2NaO3 591.3324, found 
591.3270. 
 
(17β)-N-((t-butylcarbamoyl)methyl)-N-(2-fluorophenyl)-4,4-dimethyl-3-hydroxyandrost-
5-ene-17-carboxamide  (5f) 
Colourless oil. HRMS (ESI+): calculated for [M+Na+] C34H49FN2NaO3 575.3619, found 
575.3618. 
 
(17β)-N-((t-butylcarbamoyl)methyl)-N-(2-ethyl-6-methylphenyl-4,4-dimethyl-3-
hydroxyandrost-5-ene-17-carboxamide  (5g) 
Colourless oil. HRMS (ESI+): calculated for [M+H+] C37H57N2O3 577.4364, found 
577.4414. 
  
 
(17β)-N-((t-butylcarbamoyl)methyl)-N-(2-naphthyl)-4,4-dimethyl-3-hydroxyandrost-5-
ene-17-carboxamide  (5h) 
M.p.: 174ºC. HRMS (ESI+): calculated for [M+Na+] C38H52N2NaO3 607.3870, found 
607.3851. 
 
(17β)-N-((t-butylcarbamoyl)methyl)-N-(4-fluorophenyl)-4,4-dimethyl-3-hydroxyandrost-
5-ene-17-carboxamide  (5i) 
Colourless oil. HRMS (ESI+): calculated for [M+Na+] C34H49FN2NaO3 575.3619, found 
575.3675. 
 
2-(t-butylamino)-2-oxoethyl-(17β)-4,4-dimethyl-3-hydroxyandrost-5-ene-17-carboxylate 
(11). 
M.p.: 177ºC. HRMS (ESI+): calculated for [M+Na+] C28H45NNaO4 482.3241, found 
482.3312. 
 
 
BIOLOGICAL STUDIES 
Effect on Fusarium strains.  
Fungal inocula. 
Fusarium virguliforme (Centro de Referencia de Micología  Facultad de Ciencias 
Bioquímicas y Farmacéuticas. Universidad Nacional de Rosario Nº CCC220.05) and 
Fusarium solani (Instituto Spegazzini, Facultad de Ciencias Naturales y Museo, 
Universidad Nacional de La Plata  Nº LPSC868) were cultured in 3% (w/v) malt extract-
agar médium (Oxoid Ltd, Basingstoke Hants, England) in 9 cm Petri dishes at 25ºC 
and in darkness. In order to obtain the spores, fungi was cultured for 7-10 days. 
Harvesting was carried out by suspending spores in sterilized water (with 
oligoelements). Colony forming unit (CFU) values was determined by plating 10 μl of 
10-times serially diluted suspensions and counting germination spores/dilution 
concentration. 
 
Minimum inhibitory concentration by broth microdilution.  
Test compound were dissolved in methanol to a concentration of 1μg / μl. 
Microdilution was performed in sterile disposable microtitre plates (96 U-
bottomed wells). Every well was filled with 0,2 ml of 3% (w/v) sterile malt extract 
broth. Aliquots of each compound were dispensed in every well ranging from 0 to 
  
100 µM. Compounds were tested by duplicate. Stock inoculum suspension were 
adjusted to 105 CFU / ml. Ten μl were dispensed into each well, except the first row. 
The first row of the plate contains only sterile malt extract broth as negative control of 
contamination. Microtitre plates were incubated 72 hs at 25ºC in darkness and humidity 
control. Germ-tube inhibition was determined by direct observation. The minimum 
inhibitory concentration (MIC) was determined as the lowest test compound 
concentration that completely inhibits spore germination [12]. The maximum 
concentration of ethanol used did not elicit an inhibitory effect. 
 
Effect on Trypanosoma cruzi 
Epimastigotes of Trypanosoma cruzi CL Brener strain were grown in a culture medium 
containing 33 g / L brain-heart infusion; 3 g / L tryptose; 3 g / L Na2HPO4; 0.4 g / L KCl; 
0.3 g / L glucose; pH was about 7.5, without the need for adjustment. After sterilization 
(10 min at 121 °C) penicillin (100 IU/mL), streptomycin (100 mg/mL) haemin (20 
mg/mL, added as 1 ml of a 2 mg/mL solution in 0.1 N NaOH per litre of medium) and 
20% v/v heat-inactivated (45 min at 57 °C) fetal calf serum were added. Cultures were 
performed at 28 °C in 600 ml cylindrical flasks with screw caps, containing 100 ml of 
medium. Shaking was performed manually, twice a day. All cultures were started with 
inocula taken from exponential growth parasite in the same medium. The 
susceptibilities of the epimastigote form of T. cruzi to synthetic compounds were tested 
by culturing them in cell-free medium at 28°C with the inhibitors at a 100 µM final 
concentration. The inhibitory effect on T. cruzi growth was observed by reading 
parasites in a Neubauer chamber every two day for seven days [13] 
 
Effect on mammalian cells 
Cells cultures 
Simian Vero cells were grown in Eagle’s minimal essential medium (MEM) 
supplemented with 5% inactivated fetal bovine serum (FBS) and 50 µg/ml gentamicin 
(MEM 5%) and maintained after monolayer formation in MEM 1.5%. The human cancer 
cell line A549 was grown in MEM 10% and maintained after monolayer formation in 
MEM 5%.  
Treatment solutions 
Compounds were dissolved in dimethylsulfoxide and diluted with MEM 1.5% or MEM 
5% for testing. The maximum concentration of DMSO tested (1%) exhibited no toxicity 
under in vitro conditions. 
Cytotoxicity assay  
  
The compounds were evaluated for cytotoxicity by 3-(4,5-dimethylthiazol-2-yl)-5-(3- 
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay. Vero or A549 
cells were seeded in 96-well plates and grown at 37°C with 5% CO2 until monolayer 
was formed. The culture medium was replaced by fresh medium containing the 
compounds at various concentrations and cells were further incubated for 24 h or 48 h. 
Then, monolayers were subjected to MTS-based colorimetric assay for determining cell 
viability, according to the manufacturer’s instructions (CellTiter 96 AQueous One 
Solution Reagent; Promega, Leiden, The Netherlands). The absorbance at 490 nm 
was measured on a BioTek microplate reader. Results were expressed as a 
percentage of absorbance of treated cell cultures with respect to untreated ones. 
Sigmoidal dose–response curves were fitted and the CC50 values were calculated as 
the concentration of the compound that caused a 50% reduction in absorbance. 
Antiproliferative assay 
A549 cells were seeded at a density of 104 cells/well and solutions containing different 
concentration of the tested compound were added in 96-well plates. After a 48 h 
incubation period, viability was determined by the addition of 20 µL of MTS solution 
according to the manufacturer’s instructions (CellTiter 96 AQueous One Solution 
Reagent; Promega, Leiden, The Netherlands). The absorbance at 490 nm was 
measured on a BioTek microplate reader. Results were expressed as a percentage of 
absorbance of treated cell cultures with respect to untreated ones. Sigmoidal dose–
response curves were fitted and the IC50 values were calculated as the concentration of 
the compound that caused a 50% reduction in absorbance. 
 
RESULTS AND DISCUSSION 
The synthesis of the novel compounds is shown in Scheme 1. The key step implies the 
construction of the diamide side chain applying an Ugi condensation, one of the most 
versatile multicomponent reactions (MCR). The Ugi four-component reaction (U-4CR), 
which is based on the exceptional reactivity of the isocyanides functional group, occurs 
when a carbonyl compound, an amine, a carboxylic acid and an isocyanides react 
together to give an α-aminoacylamide. The structure of the reaction product can be 
easily diversified by a systematic variation of the starting materials. 
The carboxylic component for the U-4CR was obtained as depicted in Scheme 1. The 
known intermediate 6 [10], which was obtained from progesterone in three steps, was 
treated with methyl iodide and potassium t-butoxide to give the C-4 dimethylated 
ketone 7. Further hydrolysis of the methyl ester gave the desired 17β-carboxylic acid 8 
with a total yield of 12% from progesterone. 
 
  
Treatment of compound 8 with formaldehyde, an aromatic amine and t-butyl isocyanide 
gave the desired Ugi adducts. The U-4CR generally took place smoothly and in good 
yields, and worked well with a set of structurally diverse anilines (Table 1). The reaction 
was completely regioselective, providing that no reaction of the 3-keto moiety was 
observed, probably due to the much higher reactivity of formaldehyde as the carbonylic 
component. Nevertheless all reactions gave a small amount of compound 10, a by-
product coming from the Passerini condensation  [14]. 
Following this procedure a set of nine compounds was obtained (9a-i), which were 
treated with sodium borohydryde to give the corresponding 3β-hydroxy compounds 5a-
i, the target sterol analogues. Finally, reduction of compound 10 gave the analogue 11 
with almost quantitative yield. 
The structures of intermediates 7, 8 and some representative members of the library 
were fully characterized by NMR spectroscopy. On the other hand, granted that the 
structures of the compounds are closely related, and in order to obtain a complete and 
unambiguous characterization of the library, we decided to perform a direct analysis of 
the purified steroids via HRESI MS. In all cases, main peaks were observed for [M+H]+ 
and [M+Na]+. Figure 3 shows a representative example spectrum for compound 9c. 
The molecular formula was shown to be C34H48N2O3 on the basis of its HRMS ESI (m/z  
533.3739 [M+H]+ and 555.3562 [M+Na]+). In all cases a product ion resulting from the 
loss of t-butylamine from the side chain was observed (structure A, in this example m/z 
460.2835). The structure of the side chain was revealed by ESI MS/MS. For example, 
in the case of 9c, the ESI MS/MS of the A ion, used as a precursor, yielded the 
products ions m/z 327.2297, 106.0639 and 299.2335, which can be assigned to 
structures B, B´ and C respectively. Fragments B and C are common to all the 
compounds analyzed, whereas ions A and B´ are characteristic for each particular 
structure because their contain the moiety coming from each different amine. In 
addition, ions showing water loss were observed for the 3β-hydroxy analogs 5a-i 
(Supplementary Material). The analysis described above was applied to all of the new 
compounds and allowed the determination of their structure unambiguously. 
 
Compounds both having 3-keto and 3β-hydroxy moieties were tested in vitro for their 
inhibitory properties towards Fusarium virguliforme, the causal agent of sudden death 
syndrome in soy bean, and Fusarium solani, that produces root rots on various crops, 
but is also involved in human mycoses [15]. Most of the new compounds showed a 
measurable antifungal activity against either of the two fungi. The results, expressed as 
their minimum inhibitory concentration (MIC) are shown in Table 2. Values for 
  
compounds 3 and 4, non-methylated at C4 and previously reported, were included for 
comparison. 
Firstly, methylation at C-4 seems to conserve, or even reduce, the antifungal activity 
(compare compounds 5b and 5c vs. their non-methylated counterparts 4 and 3 
respectively). Nevertheless, some compounds show a higher activity than that reported 
previously by us [9].  
 
In sight of these findings, we decided to evaluate the effect of the new analogs on the 
viability of mammalian cells, providing that any compound with a potential use as an 
antifungal agent should exert a selective toxicity. Thus, the in vitro cytotoxic 
concentration 50% (CC50) was determined on Vero cells; the results are shown in 
Table 2. It can be seen that several of the new compounds show a selective toxicity 
towards fungi, with no effect on Vero cells at the maximum concentration tested.  
Moreover, two of the compounds (9h and 5h) having a naphthyl subtituent in the side 
chain, resulted toxic only against F. solani and not against F. virguliforme or Vero cells, 
suggesting some selectivity on their action. 
 
On the other hand, compound 10, the by-product from the Passerini reaction, showed a 
noteworthy toxic effect on Vero cells, about five-fold higher than the rest of the analogs 
coming from the Ugi condensations, suggesting that it might have cytotoxic properties. 
Thus, as a preliminary study, we tested its action on the A549 cells, an 
adenocarcinomic human epithelial cell line. Even though compound 10 seems not to be 
quite toxic on this line (CC50 about 45 μM), its inhibitory concentration 50% is only 1.6 
μM when growing cells are treated. 
The main difference between compound 10 and the other compounds is that the side 
chain is linked by a labile ester bond to the steroidal nucleus rather than a more stable 
amide bond. To rule out the possibility that the ester bond was cleavaged during the 
assay, we measured the cytotoxycity of the acid 7 and the methyl ester 8, but none of 
them showed effect at concentrations lower than 200 μM. This might indicate that 
compound 10 is toxic itself.    
Finally, taking into account the different behaviour of these analogs on fungal and 
mammalian cells, we tested the most active compounds against Trypanosoma cruzi, 
the ethiological agent of Chagas´ disease [16]. Unfortunately, none of these analogs 
exerted a significant inhibitory effect (at a 100 µM dose) on the epimastigote form of the 
parasite.  
 
  
In conclusion, in this paper we have confirmed that the application of multicomponent 
reactions in the synthetic chemistry of steroids is a powerful tool that allows a rapid and 
efficient generation of collections of diverse compounds. On the other hand, we have 
shown that the 4,4-dimethyl substitution, not fully explored in previous research, may 
render novel synthetic analogs with a variety of biological effects, such as antifungal 
and cytotoxic activities. Encouraged by these findings, we are currently performing 
further studies in order to develop both structure-activity relationships and to gain 
insight into the mechanism of action of the new compounds in relevant biological 
systems. 
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Table 1. Yields of Ugi reactions. 
 
Table 2. Biological activity of the new 4,4-dimethyl sterol analogues. 
 
Figure 1. Known non natural 4,4-dimethylsterols with biological activity. 
 
Figure 2. Previously synthesised sterol analogs and general structure of new 
4,4-dimethyl derivatives. 
 
Figure 3. Representative example for the structural determination by HRMS. 
 
Scheme 1. Synthesis of new 4,4-dimethyl sterol analogues. Reactives and 
conditions: a. t-BuOK / CH3I / THF / 0°C, 1 hour. b. KOH / water / ethylene 
  
glycol / reflux, 20 minutes. c. R-NH2 / HCHO / t-BuNC / MeOH / r.t., 3 days. d. 
NaBH4 / CH2Cl2 / MeOH / r.t., 15 minutes.  
  
 
 
 
  
 
 
  
  
 
  
 
 
R-NH2 Yield (%)a 
9a 
NH2
MeO
 
63 
9b 
NH2
Cl
 
71 
9c 
NH2
 
84 
9d 
NH2
Me
 
87 
9e 
NH2
Cl
 
61 
9f 
NH2
F
 
69 
9g NH2
Me
Et
 
55 
9h 
NH2
 
89 
9i 
NH2
F
 
83 
a. Isolated yields. 
  
 
 F. solani F. virguliforme Vero cells 
 
MICa MICa CC50b 
9a 27 >100 >200 
9b 35 44 >200 
9c 96 48 >200 
9d 37 92 >200 
9e 88 88 59 
9f 46 93 65 
9g 52 >100 61 
9h 26 >100 >200 
9i 18 >100 85 
5a 18 >100 >200 
5b 35 88 >200 
5c >100 96 92 
5d 46 92 >200 
5e 35 44 88 
5f >100 >100 65 
5g >100 >100 87 
5h 17 >100 >200 
5i 36 91 91 
10 55 55 14 
11 110 55 >200 
3 46 28 >200 
4 50 50 >200 
 
a Micromolar concentration.  Mean results from duplicates. The MIC of the control 
(Benomyl, a commercial antifungal) is 9 µM for both species. 
b. Micromolar concentration. Mean results from duplicates. 
  
 
 
 
 
HIGHLIGHTS 
Analogues of 4,4-dimethyl sterols with a diamide side chain were synthetized. 
The synthesis involved a multicomponent Ugi reaction. 
Some compounds showed a selective activity against the fungal plant pathogen 
Fusarium. 
A by-product of the synthesis resulted cytotoxic against mammalian cells. 
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